The pharmaceutical industry is rapidly evolving, with substantial demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a peptide hormone, is a key copyrightple of this trend. To address this demand, US-based manufacturing services are emerging. These providers offer a comprehensive suite of capabilities, from research and